Today: 15 May 2026
Lululemon Stock Sinks as Heidi O’Neill CEO Hire From Nike Fails to Calm Investors
23 April 2026
2 mins read

Lululemon Stock Sinks as Heidi O’Neill CEO Hire From Nike Fails to Calm Investors

Vancouver, British Columbia, April 23, 2026, 07:49 PDT.

Investors dumped Lululemon Athletica shares Thursday morning—stock slid roughly 12%—after the company tapped Heidi O’Neill, a former Nike executive, as its incoming chief executive. O’Neill is set to start on Sept. 8 and will also join the board, according to the company.

The hire comes as Lululemon faces pressure on several fronts. The U.S. side of the business has lost steam, and founder Chip Wilson, together with Elliott Investment Management, is pursuing a proxy fight for board seats. The stock was down 38% over the last year ahead of Thursday’s drop.

Revenue edged up 1% in the fourth quarter to $3.6 billion. Sales slipped 4% across the Americas, while international markets jumped 17%. Interim co-CEO Meghan Frank called out the push for stronger full-price sales in North America as a “key priority”—underscoring just how crucial the home market reset is right now. Lululemon

O’Neill brings over 25 years of experience from Nike, where she served as president of consumer, product and brand. At Nike, she was credited with reducing product-development timelines and getting products to market faster, according to lululemon. O’Neill will work out of Vancouver.

Marti Morfitt, executive chair at Lululemon, described O’Neill as “an inspiring leader and proven, consumer-driven brand strategist.” O’Neill laid out her focus: “accelerate product breakthroughs,” heighten the brand’s cultural relevance, and drive growth in global markets. Lululemon

Wall Street didn’t buy in. BTIG’s Janine Stichter said the market probably wouldn’t cheer the pick, pointing to O’Neill’s lengthy stint at Nike, which coincided with “many challenges that parallel the ones LULU is currently facing,” such as losing market share and a fading brand image. Reuters

Analysts from Needham and Evercore ISI pointed to the board’s pick of O’Neill over Jane Nielsen — the ex-finance chief at Ralph Lauren and Coach, and Elliott’s preferred candidate — as another factor behind the selloff. BNP Paribas’s Gaston Dimant said Lululemon is looking for “a turnaround CEO and not a growth CEO.” Reuters

Wilson, who holds roughly 4.3% of Lululemon, continues to push for a wider shakeup of the board. Last month, the board brought in former Levi Strauss CEO Chip Bergh, and lead director David Mussafer announced he wouldn’t seek re-election. Wilson called this “a step in the right direction,” but insists further changes are necessary. Reuters

Tough timing risk here. With O’Neill not stepping in until September, there’s a long stretch where it’s unclear if product tweaks or marketing shifts will stick. Lululemon, for its part, last month guided for 2026 revenue between $11.35 billion and $11.50 billion and projected earnings per share in a $12.10 to $12.30 range—both misses versus what analysts were looking for. The company also pointed to an expected $380 million hit from U.S. tariffs.

Meghan Frank and André Maestrini continue as interim co-chief executives until O’Neill steps in. Investors are eyeing new product launches, stronger full-price sales in North America, and any indication Lululemon will keep its edge against Nike, as well as newcomers like Alo Yoga and Vuori, before the new chief executive takes over.

Stock Market Today

  • 3 US Stocks That Doubled in a Year: Should You Buy, Hold, or Sell?
    May 15, 2026, 6:42 AM EDT. Three U.S. stocks, including Micron, have doubled or more in the past year, sparking debate among investors whether to buy, hold, or take profits. Micron's stock surged 729% driven by booming demand for high bandwidth memory (HBM) chips used in AI data centers. It posted 49% revenue growth and a six-fold jump in net income for fiscal year 2025. Despite the rally, the stock trades at a forward price-to-earnings (P/E) ratio of 7.6, lower than last year, but memory chip stocks remain highly cyclical. Investors should assess if Micron's earnings momentum and valuation are sustainable amid shifts in the semiconductor market. The narrative underscores that share price gains must be supported by equivalent earnings growth and long-term fundamentals.

Latest articles

BAT’s Velo Bet Faces a Fresh WHO Warning After Shares Hit a 52-Week High

BAT’s Velo Bet Faces a Fresh WHO Warning After Shares Hit a 52-Week High

15 May 2026
London, May 15, 2026, 11:05 BST The World Health Organization on Friday urged governments to tighten controls on nicotine pouches, putting a fresh regulatory cloud over British American Tobacco p.l.c.’s push into Velo just after the Lucky Strike maker’s shares reached a 52-week high. It matters now because BAT is leaning on smokeless products, including Velo nicotine pouches and Vuse vapes, to offset falling cigarette use. The timing is awkward: investors this week bid up tobacco stocks after the U.S. Food and Drug Administration softened its enforcement stance on some under-review vapes and nicotine pouches. BAT’s London-listed shares closed 3.22%
MRNO Stock Just Jumped Before the Bell. The Bigger Murano Global Test Is Still Ahead

MRNO Stock Just Jumped Before the Bell. The Bigger Murano Global Test Is Still Ahead

15 May 2026
Murano Global Investments shares surged 67% to $0.49 in U.S. premarket trading Friday on heavy volume, after weeks under pressure from debt issues and a Nasdaq listing warning. The stock closed at $0.29 Thursday and faces an Oct. 5 deadline to regain compliance with Nasdaq’s $1 minimum bid rule. Murano is late filing its annual report and has warned of “substantial doubt” about its ability to continue as a going concern.
Mobix Labs Stock Soars 79% After Rare-Earth Deal Plan — Why MOBX Is Suddenly in the China Supply-Chain Fight

Mobix Labs Stock Soars 79% After Rare-Earth Deal Plan — Why MOBX Is Suddenly in the China Supply-Chain Fight

15 May 2026
Mobix Labs shares jumped 78.74% to $3.11 Thursday after it signed a non-binding letter of intent to acquire Special Project Delivery, a U.S. critical-minerals and energy-storage platform. The company also amended a convertible note with Leviston Resources, raising principal to $4 million for $833,000 in new cash. SPD was formed in 2019 and is based in Newport Beach, California.
HCW Biologics Stock News: Profit, Pipeline and Nasdaq Risk Put HCWB Back in Focus

HCW Biologics Stock News: Profit, Pipeline and Nasdaq Risk Put HCWB Back in Focus

15 May 2026
HCW Biologics posted first-quarter net income of $3.47 million on $6.54 million in revenue, reversing a year-earlier loss, after a licensing deal with Beijing-based Trimmune Biotech. The company remains below Nasdaq’s $1 minimum bid and awaits early human data from its lead autoimmune drug, HCW9302, in alopecia areata. HCW also reported positive animal study results for a lung drug targeting premature infants.
Palantir Stock Falls 5% Despite $300 Million USDA Deal as Software Stocks Slide (Reuters)
Previous Story

Palantir Stock Falls 5% Despite $300 Million USDA Deal as Software Stocks Slide (Reuters)

GameStop Stock Today: GME Slips as $420 Trade-In Buzz Fades and Valuation Debate Returns
Next Story

GameStop Stock Today: GME Slips as $420 Trade-In Buzz Fades and Valuation Debate Returns

Go toTop